Mastering the nuances of disputes and regulatory enforcement in life sciences is essential for legal practitioners who aim to safeguard their clients' interests. Stay ahead with practical insights and effective strategies to manage conflicts, navigate regulatory landscapes, and mitigate risks.
This week's edition of Life Sciences weekly highlights includes a key Patents Court judgment in Aristo Pharma GmbH v Takeda Pharmaceuticals USA...
The Council of the European Union has adopted the ‘pharma package’, a set of rules intended to increase patients’ access to medicines and make the EU...
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that Kenneth George Harrison has been sentenced following his conviction...
This week's edition of Life Sciences weekly highlights includes news that the Court of Justice of the European Union has handed down two judgments...
Introduction to technology transfer agreements in the Life Sciences industryWhat is a technology transfer agreement?The term ‘technology transfer...
Regulation of cosmetic products in the UKThis Practice Note provides an overview of the UK regulatory framework for cosmetics. It sets out the legal...
Intellectual property protection for medical devicesChanges to intellectual property (IP) law from 1 January 2021Before discussing how intellectual...
Second and subsequent medical use patent claimsBackground to medical use claimsSecond (and subsequent) medical use patent claims are specific to the...
Priority between loss reliefs in loss making companiesWhy does it matter?A company that is a member of a group and has incurred any of the types of losses available for surrender by way of group relief may, without any further rules, have more than one way in which to use the loss. There are a
If a rentcharge is shown as being informally exonerated on title information, does this apply to the current registered owner? Or does the informal exoneration only apply to the parties to the document which informally exonerated the rentcharge?This Q&A considers the situation where, at some point
If a beneficiary signs a deed of disclaimer of their share of an estate and the estate pays their legal fees, will that count as a PET against their estate?A disclaimer is the refusal of a gift prior to acceptance. The refusal of the gift must take place before the beneficiary accepts any benefit
Template for regulatory references given by SMCR firms and disclosure requirements[Insert addressee details]Dear [insert name][It is our understanding that [insert name of prospective employee] [was an employee of yours between the dates of [insert dates as appropriate] OR is a current employee of
0330 161 1234